Literature DB >> 18544665

Mutations of the GABA-A receptor alpha1 subunit M1 domain reveal unexpected complexity for modulation by neuroactive steroids.

Gustav Akk1, Ping Li, John Bracamontes, David E Reichert, Douglas F Covey, Joe Henry Steinbach.   

Abstract

Neuroactive steroids are among the most efficacious modulators of the mammalian GABA-A receptor. Previous work has proposed that receptor potentiation is mediated by steroid interactions with a site defined by the residues alpha1Asn407/Tyr410 in the M4 transmembrane domain and residue alpha1Gln241 in the M1 domain. We examined the role of residues in the alpha1 subunit M1 domain in the modulation of the rat alpha1beta2gamma2L GABA-A receptor by neuroactive steroids. The data demonstrate that the region is critical to the actions of potentiating neuroactive steroids. Receptors containing the alpha1Q241W or alpha1Q241L mutations were insensitive to (3alpha,5alpha)-3-hydroxypregnan-20-one (3alpha5alphaP), albeit with different underlying mechanisms. The alpha1Q241S mutant was potentiated by 3alpha5alphaP, but the kinetic mode of potentiation was altered by the mutation. It is noteworthy that the alpha1Q241L mutation had no effect on channel potentiation by (3alpha,5alpha)-3-hydroxymethyl-pregnan-20-one, but mutation of the neighboring residue, alpha1Ser240, prevented channel modulation. A steroid lacking an H-bonding group on C3 (5alpha-pregnan-20-one) potentiated the wild-type receptor but not the alpha1Q241L mutant. The findings are consistent with a model in which the alpha1Ser240 and alpha1Gln241 residues shape the surface to which steroid molecules bind.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18544665      PMCID: PMC2701692          DOI: 10.1124/mol.108.048520

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  26 in total

1.  Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.

Authors:  K Brejc; W J van Dijk; R V Klaassen; M Schuurmans; J van Der Oost; A B Smit; T K Sixma
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

2.  Molecular dynamics simulations to determine the optimal loop length in the helix-loop-helix motif.

Authors:  Hsuan-Liang Liu; Yann-Chi Shu; Yann-Huei Wu
Journal:  J Biomol Struct Dyn       Date:  2003-06

3.  Effects of gamma2S subunit incorporation on GABAA receptor macroscopic kinetics.

Authors:  A J Boileau; T Li; C Benkwitz; C Czajkowski; R A Pearce
Journal:  Neuropharmacology       Date:  2003-06       Impact factor: 5.250

4.  MUSCLE: multiple sequence alignment with high accuracy and high throughput.

Authors:  Robert C Edgar
Journal:  Nucleic Acids Res       Date:  2004-03-19       Impact factor: 16.971

5.  Pregnenolone sulfate modulates inhibitory synaptic transmission by enhancing GABA(A) receptor desensitization.

Authors:  W Shen; S Mennerick; D F Covey; C F Zorumski
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

6.  Modulation of GABA(A) receptor channel gating by pentobarbital.

Authors:  J H Steinbach; G Akk
Journal:  J Physiol       Date:  2001-12-15       Impact factor: 5.182

7.  Effects on gamma-aminobutyric acid (GABA)(A) receptors of a neuroactive steroid that negatively modulates glutamate neurotransmission and augments GABA neurotransmission.

Authors:  S Mennerick; C M Zeng; A Benz; W Shen; Y Izumi; A S Evers; D F Covey; C F Zorumski
Journal:  Mol Pharmacol       Date:  2001-10       Impact factor: 4.436

8.  Selective antagonism of 5alpha-reduced neurosteroid effects at GABA(A) receptors.

Authors:  Steven Mennerick; Yejun He; Xin Jiang; Brad D Manion; Mingde Wang; Amanda Shute; Ann Benz; Alex S Evers; Douglas F Covey; Charles F Zorumski
Journal:  Mol Pharmacol       Date:  2004-05       Impact factor: 4.436

9.  Neuroactive steroids have multiple actions to potentiate GABAA receptors.

Authors:  Gustav Akk; John R Bracamontes; Douglas F Covey; Alex Evers; Tim Dao; Joe Henry Steinbach
Journal:  J Physiol       Date:  2004-05-14       Impact factor: 5.182

10.  Mechanisms of potentiation of the mammalian GABAA receptor by the marine cembranoid eupalmerin acetate.

Authors:  P Li; D E Reichert; A D Rodríguez; B D Manion; A S Evers; V A Eterović; J H Steinbach; G Akk
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

View more
  54 in total

1.  Neurosteroid analog photolabeling of a site in the third transmembrane domain of the β3 subunit of the GABA(A) receptor.

Authors:  Zi-Wei Chen; Brad Manion; R Reid Townsend; David E Reichert; Douglas F Covey; Joe Henry Steinbach; Werner Sieghart; Karoline Fuchs; Alex S Evers
Journal:  Mol Pharmacol       Date:  2012-05-30       Impact factor: 4.436

2.  Occupation of either site for the neurosteroid allopregnanolone potentiates the opening of the GABAA receptor induced from either transmitter binding site.

Authors:  John Bracamontes; Megan McCollum; Caroline Esch; Ping Li; Jason Ann; Joe Henry Steinbach; Gustav Akk
Journal:  Mol Pharmacol       Date:  2011-04-15       Impact factor: 4.436

3.  Neurosteroids allosterically modulate binding of the anesthetic etomidate to gamma-aminobutyric acid type A receptors.

Authors:  Guo-Dong Li; David C Chiara; Jonathan B Cohen; Richard W Olsen
Journal:  J Biol Chem       Date:  2009-03-12       Impact factor: 5.157

4.  Tryptophan mutations at azi-etomidate photo-incorporation sites on alpha1 or beta2 subunits enhance GABAA receptor gating and reduce etomidate modulation.

Authors:  Deirdre Stewart; Rooma Desai; Qi Cheng; Aiping Liu; Stuart A Forman
Journal:  Mol Pharmacol       Date:  2008-09-19       Impact factor: 4.436

Review 5.  Neurosteroids and GABAergic signaling in health and disease.

Authors:  Georgina MacKenzie; Jamie Maguire
Journal:  Biomol Concepts       Date:  2013-02

6.  Neurosteroid analogues. 18. Structure-activity studies of ent-steroid potentiators of γ-aminobutyric acid type A receptors and comparison of their activities with those of alphaxalone and allopregnanolone.

Authors:  Mingxing Qian; Kathiresan Krishnan; Eva Kudova; Ping Li; Brad D Manion; Amanda Taylor; George Elias; Gustav Akk; Alex S Evers; Charles F Zorumski; Steven Mennerick; Douglas F Covey
Journal:  J Med Chem       Date:  2013-12-24       Impact factor: 7.446

7.  Alphaxalone Binds in Inner Transmembrane β+-α- Interfaces of α1β3γ2 γ-Aminobutyric Acid Type A Receptors.

Authors:  Alexis M Ziemba; Andrea Szabo; David W Pierce; Marian Haburcak; Alex T Stern; Anahita Nourmahnad; Elizabeth S Halpin; Stuart A Forman
Journal:  Anesthesiology       Date:  2018-02       Impact factor: 7.892

8.  Steroid interaction with a single potentiating site is sufficient to modulate GABA-A receptor function.

Authors:  John R Bracamontes; Joe Henry Steinbach
Journal:  Mol Pharmacol       Date:  2009-01-28       Impact factor: 4.436

9.  Tryptophan and Cysteine Mutations in M1 Helices of α1β3γ2L γ-Aminobutyric Acid Type A Receptors Indicate Distinct Intersubunit Sites for Four Intravenous Anesthetics and One Orphan Site.

Authors:  Anahita Nourmahnad; Alex T Stern; Mayo Hotta; Deirdre S Stewart; Alexis M Ziemba; Andrea Szabo; Stuart A Forman
Journal:  Anesthesiology       Date:  2016-12       Impact factor: 7.892

10.  Kinetic and structural determinants for GABA-A receptor potentiation by neuroactive steroids.

Authors:  Gustav Akk; Douglas F Covey; Alex S Evers; Steven Mennerick; Charles F Zorumski; Joe Henry Steinbach
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.